ReviewBioMed research international2026
Advances of Green-Synthesized Nanoparticles for Biomedical Applications.
Review in BioMed research international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Phytogenic Nanoparticles for Parkinson's Disease Therapy: Mechanistic Insights, Brain-Targeted Delivery and Neuroprotective Potential.Molecular neurobiology · 2026Review
- Nanoparticles for Drug Delivery: Design, Mechanisms, and Clinical Translation.Molecules (Basel, Switzerland) · 2026Review
- Silver-LoadedMarine drugs · 2026Article
- Advances of Green-Synthesized Nanoparticles for Biomedical Applications.BioMed research international · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In biomedical nanotechnology, plant-mediated production of metallic nanoparticles has become a viable and physiologically adaptable method that offers decreased toxicity, enhanced biocompatibility, and functional surface modification by phytochemical capping. In addition to altering physicochemical characteristics, including size, shape, crystallinity, and surface charge, plant extracts also function as reducing, stabilizing, and capping agents, allowing for controlled nanoparticle production. Antimicrobial efficacy, cytotoxic selectivity, antioxidant activity, and interactions with mammalian cells are among the properties that significantly influence biological performance. The mechanistic knowledge of nanoparticle production and structure-activity correlations has been made easier by developments in spectroscopic, microscopic, and surface analytical methods. When taken as a whole, plant-derived nanoparticles show encouraging biomedical potential in antimicrobial therapy, anticancer applications, wound healing, and drug delivery assisted by nanocarriers. However, they also pose issues with standardization, reproducibility, and translational scalability. This semisystematic review summarizes recent advancements in the synthesis, characterization, and biomedical applications of plant-derived nanoparticles, highlighting quantitative trends, mechanistic insights, and important knowledge gaps pertinent to future clinical translation. It covers literature from 2015 to 2024 and analyzes over 120 studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.